V. Maclachlan

发表

Luteinizing‐Hormone‐Releasing Hormone Agonist Treatment in Patients with Previously Failed Folliculogenesis during in Vitro Fertilization Therapy a

A. Trounson, V. Maclachlan, M. Besanko, 1988, Annals of the New York Academy of Sciences.

Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle.

A. Trounson, L. Rombauts, V. Maclachlan, 1998, Fertility and sterility.

Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology.

R. Koistinen, M. Seppälä, V. Maclachlan, 1996, Fertility and sterility.

Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment.

C. Wood, V. Maclachlan, D. Healy, 1998, Fertility and sterility.

The incidence of hypertensive disorders of pregnancy following sperm donation in IVF: an Australian state-wide retrospective cohort study.

B. Vollenhoven, S. Walker, A. Lindquist, 2019, Human reproduction.

What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction.

V. Maclachlan, D. Healy, J. Min, 2004, Human reproduction.

Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration.

H. Burger, R. Mclachlan, V. Maclachlan, 1988, The Journal of clinical endocrinology and metabolism.

Replacement of one selected embryo is just as successful as two embryo transfer, without the risk of twin pregnancy

L. Rombauts, G. Kovacs, V. Maclachlan, 2003, The Australian & New Zealand journal of obstetrics & gynaecology.

A prospective study of inhibin in granulosa cell tumors of the ovary.

H. Burger, M. Quinn, P. Mamers, 1994, Gynecologic oncology.

The Effects of Adjuvant Therapies on Embryo Transfer Success

B. Vollenhoven, M. Healey, V. Maclachlan, 2017, Journal of reproduction & infertility.

A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate) for folliculogenesis in routine in vitro fertilization patients.

C. Wood, V. Maclachlan, D. Healy, 1991, Fertility and sterility.

Do raised serum luteinizing hormone levels during stimulation for in‐vitro fertilization predict outcome?

A. Thomas, V. Maclachlan, M. Besanko, 1989, British journal of obstetrics and gynaecology.

A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.

A. Trounson, C. Wood, V. Maclachlan, 1989, The New England journal of medicine.

The success rate of IVF has significantly improved over the last decade

G. Kovacs, V. Maclachlan, J. Wade, 2015, The Australian & New Zealand journal of obstetrics & gynaecology.

Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome.

D. D. de Kretser, N. Groome, V. Maclachlan, 2000, Human reproduction.

Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone.

N. Groome, D. Robertson, V. Maclachlan, 2000, The Journal of clinical endocrinology and metabolism.

Can you ever collect too many oocytes?

H. Baker, G. Kovacs, V. Maclachlan, 2015, Human reproduction.

School-age outcomes among IVF-conceived children: A population-wide cohort study

L. Gurrin, J. Cheong, B. Vollenhoven, 2023, PLoS medicine.

Should intrauterine human chorionic gonadotropin infusions ever be used prior to embryo transfer?

B. Vollenhoven, M. Healey, V. Maclachlan, 2018, Journal of Assisted Reproduction and Genetics.

Predicting pregnancy outcome after in vitro fertilization and embryo transfer using estradiol, progesterone, and human chorionic gonadotropin beta-subunit.

A. Thomas, V. Maclachlan, D. Healy, 1989, Fertility and sterility.

Sex ratio and birth weights of infants born as a result of blastocyst transfers compared with early cleavage stage embryo transfers.

A. Trounson, G. Jones, V. Maclachlan, 2001, Fertility and sterility.

Is the luteo-placental shift a myth? Analysis of low progesterone levels in successful art pregnancies.

V. Maclachlan, M. Besanko, D. Healy, 1993, The Journal of clinical endocrinology and metabolism.

Different influence of incongruent follicular development on in vitro fertilization-embryo transfer and gamete intrafallopian transfer pregnancy rates.

L. Rombauts, V. Maclachlan, D. Healy, 1998, Fertility and sterility.

Optimizing outcome in assisted reproduction reducing multiple pregnancy

L. Rombauts, G. Kovacs, V. Maclachlan, 2004 .

Basics of ovarian stimulation

G. Baker, V. Maclachlan, D. Healy, 2007 .

Serum immunoactive inhibin levels in early pregnancy after in vitro fertilization and embryo transfer.

D. Robertson, D. D. de Kretser, V. Maclachlan, 1993, Fertility and sterility.

Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.

V. Maclachlan, A. Suikkari, D. L. Healy, 1995, Human reproduction.

The Effects of Adjuvant Therapies on Embryo Transfer Success

B. Vollenhoven, M. Healey, V. Maclachlan, 2017, Journal of reproduction & infertility.